Paz-Ares, L. G., O'Byrne, K. J., Johnson, M. L., Reck, M., Girard, N., Hayashi, H., Zhou, C., Gharpure, V. S., Pisupati, R., Pacius, M., Ready, N. E. (2025). The TIGOS trial: A randomized, double-blind phase 3 trial of atigotatug + nivolumab fixed-dose combination with chemotherapy vs atezolizumab with chemotherapy in patients with 1L extensive-stage small cell lung cancer (ES-SCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8127